Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jay silberman who wrote (154)	1/16/1997 1:15:00 AM
From: Peter Church	of 6136

Hi, I've been following this company for a while and have enjoyed reading your comments. Some good news will most likely appear on January 22 at the Anti Retroviral Conference in Washington (IDSA meeting). Agouron will release the results of their Phase III clinical trials there. From all reports, the news will be very good. I think that takes virtually all the risk out of the FDA approval process. The only doubts I have about the stock's performance are related to the rapid ascent since last July. Could it be that the good news is already calculated into the price? I am voting no and buying again now before the news hits street. ....Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next